1620 Investment Advisors, Inc. Elanco Animal Health Inc Transaction History
1620 Investment Advisors, Inc.
- $126 Million
- Q4 2024
A detailed history of 1620 Investment Advisors, Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 43 shares of ELAN stock, worth $489. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43
Previous 43
-0.0%
Holding current value
$489
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ELAN
# of Institutions
449Shares Held
480MCall Options Held
4.47MPut Options Held
730K-
Dodge & Cox San Francisco, CA83.3MShares$948 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$582 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$555 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$265 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$242 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.4B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...